This announcement is a separate document:
昭衍新药：北京昭衍新药研究中心股份有限公司2022年前3季度业绩预增公告
Zhaoyan Pharmaceutical: Beijing Zhaoyan New Drug Research Center Co., Ltd.'s performance forecast increase announcement for the first 3 quarters of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.